StreetAlpha
13F holdings · Q3 2026

HighVista Strategies

Boston, MA · files as HighVista Strategies LLC
Know the moment HighVista Strategies filesYou follow HighVista Strategies An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Holdings as of Sep 30, 2026Filed Nov 13, 2026Next filing due Feb 15, 2027CIK 1335325

HighVista Strategies reported 136 stocks worth $381M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are DBC (9.0%), RVMD (2.5%) and ABVX (2.3%). Compared with Q2 2026, the fund opened new positions in GMAB, MANE and CTNM, added to TNGX, TARS and COGT, trimmed RVMD, ABVX and PCVX and sold out of ALMS, MLYS and EYPT.

Latest filing: what HighVista Strategies did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
24 new48 added63 trimmed35 sold outBought about $86.2M · sold about $107M
New 24
See all 24 →
Added 48
See all 48 →
Trimmed 63
See all 63 →
Sold out 35
See all 35 →

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$381M−13.2% vs last quarter
Stocks held13624 new · 35 sold out
Top 5 weight17.9%spread out
Turnover56%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
DBC
Invsc DB Commodity Index
$34.2M9.0%1.1MNo change8 of 8
2
RVMD
Revolution Medicines Inc
$9.4M2.5%46K−21K (−31%)8 of 8
3
ABVX
Abivax SA
$8.6M2.3%87K−26K (−23%)8 of 8
4
PCVX
Vaxcyte Inc
$8.1M2.1%142K−7,632 (−5%)8 of 8
5
GMAB
Genmab A/s
$8.1M2.1%226KNew position1 of 8
6
RLAY
Relay Therapeutics Inc
$7.4M1.9%409K−97K (−19%)6 of 8
7
TNGX
Tango Therapeutics Inc
$7.2M1.9%288K+28K (+11%)3 of 8
8
TARS
Tarsus Pharmaceuticals Inc
$7.1M1.9%90K+3,372 (+4%)6 of 8
9
IMVT
Immunovant Inc
$7M1.8%206K−72K (−26%)7 of 8
10
COGT
Cogent Biosciences Inc
$6.7M1.8%210K+21K (+11%)8 of 8
🔒 126 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
ALMS
Alumis Inc
$5.6M200K
MLYS
Mineralys Therapeutics Inc
$2.3M86K
EYPT
Eyepoint Pharmaceuticals Inc
$2.2M156K
RBC
RBC Bearings Inc
$2.1M3,223
RKT
Rocket Companies Cla A
$2M126K

🔒 Free account: see all 30.

Reported value

last 8 quarters
$269MQ4 '24
$260MQ1 '25
$272MQ2 '25
$408MQ3 '25
$388MQ4 '25
$362MQ1 '26
$439MQ2 '26
$381MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 13, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

HighVista Strategies 13F FAQ

What does HighVista Strategies own?

HighVista Strategies reported 136 stocks worth $381M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are DBC (9.0%), RVMD (2.5%) and ABVX (2.3%). The table above lists every position in the filing (the top 10 without an account).

What did HighVista Strategies buy and sell in Q3 2026?

Compared with Q2 2026: 24 new positions, 48 added to, 63 trimmed and 35 sold out. New positions include GMAB, MANE and CTNM. It sold all of ALMS, MLYS and EYPT.

When will HighVista Strategies file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is HighVista Strategies's portfolio worth?

The Q3 2026 filing reports $381M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.